In recent years, recommendations for prostate cancer screening have been caught amidst growing controversy. The utility of prostate-specific antigen (PSA) testing, the most prominent front-line screening exam for prostate cancer has been heavily critiqued. Meanwhile, numerous men present with incurable late-stage prostate cancer while men with low-risk, indolent disease receive treatment that offers little benefit in terms of health outcomes. Prostate cancer patients and their physicians have long sought an alternative to the current standard of care in prostate […]
Digital breast tomosynthesis, also known as 3D mammography, refers to a relatively new breast imaging technology approved for use in the United States in 2011.
Like conventional mammography, 3D mammography uses X-rays to create visual representations of internal breast tissue for the purpose of identifying tumors, lumps and other abnormalities. However, 3D mammography can produce more detailed images than conventional mammography.
During conventional mammography, two images of each breast are taken: a top-to-bottom view and a side-to-side view. During 3D mammography, […]
Annual mammogram screening beginning at age 40 saves lives. U.S. Preventive Services Task Force (USPSTF) recommends less frequent screening at a later age, not because screening will not save lives, but because it will not save sufficient numbers of lives when started before age 50.
The guidelines are based on outdated, blemished data and do not evaluate cost-effectiveness or any other benefits of early detection. In fact, USPSTF states, “Screening mammography in women ages 40 to 49 years may reduce the […]
On Feb 5, 2015, CMS announced the final decision to cover low-dose computed tomography (LDCT) lung cancer screening in high-risk patients. LDCT lung cancer screening has the potential to save more lives than any other lung cancer screening test yet developed. Despite a 32 percent reduction in lung cancer mortality between 1975 and 2000, lung cancer is still the leading cause of cancer death in the United States and accounted for 27 percent of all cancer deaths in 2014. […]
Ongoing research has consistently shown that multiparametric prostate MRI can aid prostate cancer screening and improve detection rates. New results to a large-scale study investigating the effectiveness of MRI-TRUS fusion biopsy versus traditional TRUS biopsy demonstrate the superiority of multiparametric prostate MRI in prostate cancer detection.
MRI-TRUS Fusion Biopsy Versus Traditional TRUS Biopsy
In a study sponsored by the National Institute of Health, more than 1,000 men with elevated PSA levels were observed over a period of seven years. The purpose […]